Location: New York NY, Hackensack NJ, Tampa FL, Houston TX,
Sponsor: Orca Biosystems, Inc.
Sex: All
Age: 12 - 70+
Code: NCT03802695
Phase1, Recruiting
Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02
for
Acute Myeloid Leukemia, Myelodysplastic Syndrome
Location: Fairway KS
Sponsor: Celyad Oncology SA
Sex: All
Age: 18+
Code: NCT04167696
Phase1, Recruiting
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation
Sponsor: University of North Carolina, Chapel Hill
Sex: Female
Age: 12 - 70+
Code: NCT05484804
Recruiting
Phenotyping Response to Spinal Cord Stimulation in Chronic Low Back Pain
for
Chronic Low Back Pain
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18 - 70+
Code: NCT06310226
Recruiting
Manual and Manipulative Therapy for Low Back Pain
for
Low Back Pain
Location: El Paso TX
Sponsor: Samueli Institute for Information Biology
Sex: All
Age: 18 - 35
Code: NCT00632060
Recruiting
A Prospective Cohort Study of Basivertebral Nerve Ablation Using the Stryker OptaBlate BVN System for the Treatment of Vertebrogenic Low Back Pain
for
Verteborgenic Low Back Pain, Back Pain Lower Back
Location: Fort Lauderdale FL
Sponsor: Stryker Instruments
Sex: All
Age: 22+
Code: NCT07392333
Recruiting
Brain Imaging Biomarkers for Response to Spinal Cord Stimulation in Patients With Chronic Low Back Pain
for
Chronic Low-back Pain
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 21+
Code: NCT04658628
Recruiting
Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies
for
Leukemia, Acute, MDS
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All
Age: 60+
Code: NCT03680677
Recruiting
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Boston MA, St Louis MO
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07137416
Phase1, Recruiting
Developing Evidence-Based Cognitive Approaches to Improve Adjustment to Vision Loss